These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15140620)

  • 1. Effector mechanisms in anti-MAG antibody-mediated and other demyelinating neuropathies.
    Latov N; Renaud S
    J Neurol Sci; 2004 May; 220(1-2):127-9. PubMed ID: 15140620
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-MAG antibody associated neuropathy].
    Ogino M; Saito T
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):487-91. PubMed ID: 10434706
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-myelin-associated glycoprotein neuropathy.
    Steck AJ; Stalder AK; Renaud S
    Curr Opin Neurol; 2006 Oct; 19(5):458-63. PubMed ID: 16969155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy.
    Dalakas MC; Rakocevic G; Salajegheh M; Dambrosia JM; Hahn AF; Raju R; McElroy B
    Ann Neurol; 2009 Mar; 65(3):286-93. PubMed ID: 19334068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three different anti-myelin antibodies in a case of demyelinating dysglobulinemic peripheral neuropathy.
    Ellie E; Younes-Chennoufi AB; Couto A; Vital A; Hilmi S; Demotes-Mainard J; Baumann N; Petry KG
    J Peripher Nerv Syst; 1997; 2(1):43-8. PubMed ID: 10975735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelin-associated glycoprotein in demyelinating disorders.
    Quarles RH
    Crit Rev Neurobiol; 1989; 5(1):1-28. PubMed ID: 2475262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody testing in peripheral neuropathies.
    Vernino S; Wolfe GI
    Neurol Clin; 2007 Feb; 25(1):29-46. PubMed ID: 17324719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic demyelinating neuropathy associated with antibodies to myelin associated glycoprotein.
    Steck AJ
    Riv Neurobiol; 1984; 30(2-3):179-86. PubMed ID: 6085774
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunodetection of anti-MAG IgM antibody by cross-reactivity to LA-N-1 neuroblastoma cells.
    Isoardo G; Deaglio S; Cocito D; Migliaretti G; Ferrero E; Cavallo F; Durelli L; Malavasi F
    J Neuroimmunol; 2005 Apr; 161(1-2):78-86. PubMed ID: 15748946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Low concentration monoclonal IgM and demyelinating peripheral neuropathy].
    Dehan C; Olivier M; Bohand S; Bohand X; Maslin J; Moalic JL
    Ann Biol Clin (Paris); 1999; 57(2):221-3. PubMed ID: 10210751
    [No Abstract]   [Full Text] [Related]  

  • 11. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
    Brannagan TH
    Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of the anti-IgM SGPG Elisa (Bühlmann laboratories AG) in 147 sera with a monoclonal IgM anti-MAG/SGPG antibody-associated neuropathy].
    Caudie C; Bouhour F; Petiot P; Gonnaud PM; Antoine JC; Vial C
    Ann Biol Clin (Paris); 2007; 65(4):369-75. PubMed ID: 17627917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effector mechanisms in demyelinating neuropathies.
    Hartung HP; Zielasek J; Jung S; Toyka KV
    Rev Neurol (Paris); 1996 May; 152(5):320-7. PubMed ID: 8881423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-myelin associated glycoprotein neuropathy responding to lenalidomide.
    Larsen LH; Lund T; Vilholm OJ; Plesner T
    Leuk Res; 2011 Nov; 35(11):e198-9. PubMed ID: 21802139
    [No Abstract]   [Full Text] [Related]  

  • 15. [Autoimmune peripheral neuropathies with anti-MAG antibodies and hematological disorders. Five cases].
    Andrès E; Vinzio S; Maloisel F; Carre S; Perrin AE; Goichot B; Schlienger JL
    Ann Med Interne (Paris); 2001 Apr; 152(3):147-51. PubMed ID: 11431571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCV-related central and peripheral nervous system demyelinating disorders.
    Mariotto S; Ferrari S; Monaco S
    Inflamm Allergy Drug Targets; 2014; 13(5):299-304. PubMed ID: 25198705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies?
    Nobile-Orazio E; Gallia F; Terenghi F; Allaria S; Giannotta C; Carpo M
    J Neurol Sci; 2008 Mar; 266(1-2):156-63. PubMed ID: 17915254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurosurgical treatment of tremor in anti-myelin-associated glycoprotein neuropathy.
    McMaster J; Gibson G; Castro-Prado F; Vitali A; Honey CR
    Neurology; 2009 Nov; 73(20):1707-8. PubMed ID: 19917996
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum CXCL13 reflects local B-cell mediated inflammatory demyelinating peripheral neuropathy.
    Kim YH; Jang SY; Shin YK; Jo YR; Yoon BA; Nam SH; Choi BO; Shin HY; Kim SW; Kim SH; Kim JK; Park HT
    Sci Rep; 2019 Nov; 9(1):16535. PubMed ID: 31712675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demyelinating peripheral neuropathy associated with hemophagocytic lymphohistiocytosis. An immuno-electron microscopic study.
    De Armas R; Sindou P; Gelot A; Routon MC; Ponsot G; Vallat JM
    Acta Neuropathol; 2004 Oct; 108(4):341-4. PubMed ID: 15243760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.